The future of customer experience isn’t about deploying more AI tools—it’s about orchestrating them across organizational boundaries. Companies that master this symphony will outperform those focused on automation alone.
While companies pour billions into AI technology, research shows culture may be the deciding factor in achieving real returns. New surveys reveal why leadership and organizational dynamics separate AI winners from strugglers.
Google’s AI infrastructure chief reveals the company is turning away TPU customers as demand overwhelms supply. Even 8-year-old hardware runs at maximum capacity, highlighting the AI compute crisis.
Wall Street analysts delivered mixed verdicts on tech giants and consumer stocks Thursday. While AI leaders like Nvidia and Microsoft maintained bullish ratings, Meta faced downgrades over AI investment concerns amid broader market uncertainty.
The fight over how tech giants account for AI data center emissions has escalated to international climate standards. Google and Microsoft are pushing for mandatory hourly carbon accounting that could reshape environmental reporting.
Advanced AI is revolutionizing chip design by processing billions of design rule violations simultaneously. Siemens’ Calibre Vision AI platform clusters errors with common root causes, transforming weeks of manual work into minutes of guided analysis.
Lucy Guo’s journey from AI infrastructure billionaire to creator economy entrepreneur reveals how AI wealth is reshaping digital content markets. Her platform Passes faces both explosive growth and serious legal challenges.
The core engineers behind OpenAI’s groundbreaking Sora video generator are reuniting for an ambitious new mission: chasing artificial superintelligence. This high-risk bet could redefine AI’s future trajectory and safety landscape.
Researchers have discovered that alternative promoter usage in triple-negative breast cancer drives tumor heterogeneity and patient outcomes. The HDAC9 gene shows dramatic promoter switching that correlates with survival differences, opening new diagnostic possibilities.
Researchers have identified the first neurosteroid-binding sites within NMDA receptors, revealing distinct binding mechanisms. This discovery provides a strategic framework for developing safer neurological treatments targeting these critical brain receptors.
